Bristol-Myers Squibb agrees to pay $670 million to settle several lawsuits. The suits accused the pharmaceutical company of fraudulently restricting competitors from selling cheap copies of two of its best-selling drugs. NPR's Snigdha Prakash reports.
Copyright 2003 NPR
